Group of Companies - Research & Development

Emerald Health Research (EHR) provides additional opportunities for Emerald to spin off compounds through licensing agreements or new companies. EHR will advance the screening of the many molecules in its intellectual property portfolio in addition to pursuing new, patented molecules based on cannabis and the endocannabinoid system.